Viewing Study NCT00096850


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-02-11 @ 3:24 PM
Study NCT ID: NCT00096850
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 2004-11-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Tuberculosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV Seronegativity View
None Antitubercular agents View